BU-NOT-SET

CONTACT US
Using in vitro release testing (IVRT) to analyse semi-solid topical formulations
  • Analytical chemistry
Cream squeezed out of a tube
White paper
Enhancing the production of RNA with continuous manufacturing
  • Biologics
Continuous manufacturing of RNA
Insight
GERTEIS MINI-PACTOR® Advanced dry granulation services
  • Drug product
GERTEIS MINI-PACTOR®
Fact sheet
Overcoming oncolytic virus therapy production challenges through collaboration
  • Biologics
Oncolytic virus therapy production
Case study
Emerging trends set to impact drug development in 2024
  • Industry trends
Trends in drug development
Insight
Webinar: ATMPs in focus: Essential CMC strategies for every phase
  • Biologics
ATMPs in focus
Webinar
Trends set to make an impact on oral solid dose development in 2024
  • Drug product
  • Industry trends
Oral solid dose
Insight
Enhancing AAV therapy development and manufacture with a platform approach
  • Biologics
Enhancing AAV therapy
Insight
Challenges and solutions to enhancing mRNA stability with lyophilisation processes
  • Drug product
  • Industry trends
Lyo
Insight
Case study
  • Drug product
  • Manufacturing
Accelerating an innovative high potency oncology therapy to market
Insight
  • Manufacturing
When OSD manufacturing goes global
Insight
  • Drug product
  • Manufacturing
Ensuring Reliable HPAPI Supply
Insight
  • Drug product
  • Manufacturing
De-risking high-potency programmes
Case study
  • Analytical chemistry
  • Drug product
Analytical method development for multivitamin tablets
Insight
  • Drug product
  • Manufacturing
The evolving OSD market: Complexity, capability and collaboration
Insight
  • Drug product
  • Manufacturing
High-potency APIs and the evolving demands of drug development
White paper
  • Drug product
  • Manufacturing
Safely scaling high potency API manufacturing
Insight
  • Drug product
  • Manufacturing
From development insight to manufacturing confidence